DrugPatentWatch Database Preview

Itraconazole - Generic Drug Details

What are the generic drug sources for itraconazole and what is the scope of itraconazole freedom to operate?
Itraconazole is the generic ingredient in three branded drugs marketed by Accord Hlthcare, Alembic Pharms Ltd, Alkem Labs Ltd, Amneal Pharms, Jubilant Generics, Mylan Pharms Inc, Par Pharm Inc, Sandoz, Zydus Pharms Usa Inc, Janssen Pharms, and Sebela Ireland Ltd, and is included in fourteen NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Itraconazole has eight patent family members in five countries.

There are fifteen drug master file entries for itraconazole. Eighteen suppliers are listed for this compound.

Summary for itraconazole

International Patents:	8
US Patents:	2
Tradenames:	3
Applicants:	11
NDAs:	14
Drug Master File Entries:	15
Suppliers / Packagers:	18
Bulk Api Vendors:	53
Clinical Trials:	183
Patent Applications:	6,777
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for itraconazole
DailyMed Link:	itraconazole at DailyMed

Pharmacology for itraconazole

Ingredient-type	Azoles
Drug Class	Azole Antifungal
Mechanism of Action	Cytochrome P450 3A4 Inhibitors P-Glycoprotein Inhibitors

Medical Subject Heading (MeSH) Categories for itraconazole

14-alpha Demethylase Inhibitors
Antifungal Agents
Cytochrome P-450 CYP3A Inhibitors

US Patents and Regulatory Information for itraconazole

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan Pharms Inc	ITRACONAZOLE	itraconazole	CAPSULE;ORAL	200463-001	Jul 20, 2012	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Jubilant Generics	ITRACONAZOLE	itraconazole	CAPSULE;ORAL	203445-001	Feb 23, 2017	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Sebela Ireland Ltd	ONMEL	itraconazole	TABLET;ORAL	022484-001	Apr 29, 2010		RX	Yes	Yes	➤ Sign Up	➤ Sign Up	Y			➤ Sign Up
Janssen Pharms	SPORANOX	itraconazole	CAPSULE;ORAL	020083-001	Sep 11, 1992	AB	RX	Yes	Yes	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

or, see our see our flat-rate plans

Expired US Patents for itraconazole

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Sebela Ireland Ltd	ONMEL	itraconazole	TABLET;ORAL	022484-001	Apr 29, 2010	➤ Sign Up	➤ Sign Up
Janssen Pharms	SPORANOX	itraconazole	CAPSULE;ORAL	020083-001	Sep 11, 1992	➤ Sign Up	➤ Sign Up
Janssen Pharms	SPORANOX	itraconazole	INJECTABLE;INJECTION	020966-001	Mar 30, 1999	➤ Sign Up	➤ Sign Up
Janssen Pharms	SPORANOX	itraconazole	CAPSULE;ORAL	020083-001	Sep 11, 1992	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Non-Orange Book US Patents for itraconazole

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Patent No.	Title	Estimated Patent Expiration
9,149,431	Itraconazole compositions with improved bioavailability	➤ Sign Up
Patent No.	Title	Estimated Patent Expiration